Top

Breast Cancer Research and Treatment

Published in:

01-06-2017 | Clinical trial

Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience

Authors: Svenja Jendrian, Katharina Steffens, Barbara Schmalfeldt, Elena Laakmann, Corinna Bergelt, Isabell Witzel

Published in: Breast Cancer Research and Treatment | Issue 3/2017

Abstract

Background

Although some studies suggest that breast-conserving therapy (BCT) shows better psychosocial outcomes than mastectomy in patients with primary breast cancer, little is known about the outcomes of these surgical options in recurrent breast cancer. We investigated differences in overall survival and re-recurrence rates as well as psychosocial outcomes among patients who underwent BCT or mastectomy after the diagnosis of recurrent breast cancer in a single-center setting.

Methods

124 of 186 eligible patients who underwent surgical treatment for breast cancer recurrence completed the questionnaires on quality of life (EORTC QLQ-C30 and -BR23), fear of progression (PA-F-KF), anxiety and depression (HADS), and body image (BIS).

Results

Women after breast-conserving surgery (n = 46) showed significantly better outcomes than women after mastectomy (n = 61) with respect to body image (P < 0.001 in BIS and p < 0.001 in BR23), social functioning (p = 0.016), emotional functioning (p = 0.028), and role functioning (p = 0.043). There were no significant group differences regarding anxiety, depression, and fear of progression as well as re-recurrence and survival rates. Predictors of good quality of life were partnership (OR 2.46), higher monthly family income (OR 3.54), and higher professional qualification (OR 4.3) in our group of patients.

Discussion

Our results indicate that patients treated with breast-conserving therapy after recurrent breast cancer perceive lower impairments in body image and several aspects of quality of life than patients treated with mastectomy.

Han J, Grothuesmann D (2010) Quality of life and satisfaction after breast cancer operation. Arch Gynecol Obstet 282(1):75–82CrossRefPubMed

Arndt V et al (2008) Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study. J Cancer Res Clin Oncol 134(12):1311–1318CrossRefPubMed

Sun Y, Kim S, Heo C (2014) Comparison of quality of life based on surgical technique in patients with breast cancer. Jpn J Clin Oncol 44(1):22–27CrossRefPubMed

Lim C, Devi M (2011) Anxiety in women with breast cancer undergoing treatment: a systemic review. Int J Evid Based Healthc 9(3):215–235PubMed

Kaminska M, Kubiatowski T (2015) Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy. Ann Agric Environ Med 22(1):158–189CrossRef

Chow R, Pulenzas N, Zhang L (2016) Quality of life and symptom burden in patients with breast cancer treated with mastectomy and lumpectomy. Support Care Cancer 24(5):2191–2199CrossRefPubMed

Engel J, Kerr J, Schlesinger-Raab A (2004) Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J 10:223–231CrossRefPubMed

He Z-Y, Tong Q, Wu S-G (2012) A comparison of quality of life and satisfaction of women with early-stage breast cancer treated with breast conserving therapy versus mastectomy in southern China. Support Care Cancer 20(10):2441–2449CrossRefPubMed

Ohsumi S, Shimozuma K, Kuroi K (2007) Quality of life of breast cancer patients and types of surgery for breast cancer–current status and unresolved issues. Breast Cancer J 14(1):66–73CrossRef

10.

Montazeri A (2008) Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 27(1):32CrossRefPubMedPubMedCentral

11.

Hall A, Fallowfield L (1989) Psychological outcome of treatment for early breast cancer: a review. Stress Med 5(3):167–175CrossRef

12.

Lasry J-C, Margolese R (1992) Fear of recurrence, breast-conserving surgery, and the trade off hypothesis. Cancer 69(8):2111–2115CrossRefPubMed

13.

Constanzo E, Lutgendorf S, Mattes M (2007) Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Br J Cancer 97:1625–1631CrossRef

14.

Christ J, Grunfield EA (2013) Factors reported to influence fear of recurrence in cancer patients: a systemic review. Psychooncology 22(5):978–986CrossRef

15.

Rabin C, Leventhal H, Goodin S (2004) Conceptualization of disease timeline predicts post-treatment distress in breast cancer patients. Health Psychol 23:407–412CrossRefPubMed

16.

McGinty HL, Goldenberg JL, Jacobsen PB (2012) Relationship of threat appraisal with coping appraisal to fear of cancer recurrence in breast cancer survivors. Psychooncology 21(2):203–210CrossRefPubMed

17.

Constanzo E, Lutgendorf S, Mattes M (2007) Adjusting to life after treatment: distress and quality of life following treatment for breast cancer. Breast J Cancer 97:1625–1631

18.

Blichert-Toft M, Nielsen M, Düring M (2008) Long-term results of breast conserving surgery versus mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol 47(4):672–681CrossRefPubMed

19.

Alpert T, Kuerer H, Arthur DW (2005) Ipsilateral breast tumor recurrence after breast conserving therapy: outcomes of salvage preservation. Int J Radiat Oncol Biol Phys 63(3):845–851CrossRefPubMed

20.

Burger A, Pain S, Paley G (2013) Treatment of recurrent breast cancer following breast conserving surgery. Breast J 19(3):310–318CrossRefPubMed

21.

Peterson D, Troung P, Sadek B (2014) Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer. Ann Surg Oncol 21(11):3490–3496CrossRefPubMed

22.

Northouse L, Mood D, Kershaw T (2002) Quality of life of women with recurrent breast cancer and their family members. J Clin Oncol 20(19):4050–4064CrossRefPubMed

23.

Bull A, Meyerowitz B, Hart S (1999) Quality of life in women with recurrent breast cancer. Breast Cancer Res Treat 54(1):47–57CrossRefPubMed

24.

Hopwood P, Fletcher I, Lee A (2001) A body image scale for use with cancer patients. Eur J Cancer 37(2):189–197CrossRefPubMed

25.

Fayers P, Aaronson N, and Bjorndal K(2001) EORTC QLQ-C30 Scoring Manual, B.E.O.f.R.a.T.o. Cancer, Editor

26.

Herrmann C, Buss U, Snaith RP (1995) HADS-D Hospital anxiety and depression scale- German version. Hans Huber, Bern

27.

Mehnert A, Herschbach P, Berg P (2006) Progredienzangst bei Brustkrebspatientinnen - Validierung der Kurzform der Progredienzangstfragebogens PA-F-KF. Psychosom Med Psychother 52(3):274–288

28.

Schwarz R, HInz A (2001) Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 37(11):1345–1351CrossRefPubMed

29.

Waldmann A et al (2007) The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res 16(5):767–776CrossRefPubMed

30.

Schou I, Ekeberg O, Sandvik L (2005) Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res 14(8):1813–1823CrossRefPubMed

31.

Bernhard J, Hurny C, Maibach R (1999) Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Ann Oncol 10(7):775–782CrossRefPubMed

32.

Mols F, Vingerhoets AJ, Coebergha JW (2005) Quality of life among long-term breast cancer survivors: a systemic review. Eur J Cancer 41(17):2613–2619CrossRefPubMed

Title: Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience
Authors: Svenja Jendrian
Katharina Steffens
Barbara Schmalfeldt
Elena Laakmann
Corinna Bergelt
Isabell Witzel
Publication date: 01-06-2017
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 3/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-017-4208-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 3/2017

A83-01 inhibits TGF-β-induced upregulation of Wnt3 and epithelial to mesenchymal transition in HER2-overexpressing breast cancer cells

FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer

Ovarian suppression in combination endocrine adjuvant therapy in premenopausal women with early breast cancer

Response

Cost-effectiveness of palbociclib plus letrozole versus letrozole alone as a first-line treatment in women with oestrogen receptor-positive, HER2-negative, advanced breast cancer. Revised results for the Swiss health care setting

Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression

Keynote webinar | Spotlight on antibody–drug conjugates in cancer